Le système nerveux central est un organe privilégié et protégé, notamment grâce à l’existence des barrières histologiques entre le sang et les tissus nerveux. La barrière-hémato encéphalique (BHE) et la barrière hémato-rétinienne (BHR) séparent respectivement le parenchyme cérébral et la rétine des composés contenus dans l’espace vasculaire, grâce à l’expression de jonctions serrées et de transporteurs membranaires permettant une régulation spécifique des échanges entre le sang et le parenchyme nerveux. Ce travail a porté sur l’étude d’un nouveau transporteur de cations organiques mis en évidence fonctionnellement à la BHE de la souris. Ce transporteur appartenant très probablement à la superfamille des solute carrier (SLC), fonctionne comme un antiport proton. Actuellement, sa présence ne peut être démontrée que de façon fonctionnelle car son identité moléculaire est encore inconnue. Cet antiport proton constitue un nouvel acteur de la perméabilité cérébrale et ouvre une nouvelle voie d’accès au cerveau. Nous nous sommes tout d’abord attachés à approfondir les connaissances fonctionnelles de ce transporteur en étudiant de nouveaux substrats et tissus d’expression. Le transport cérébral de psychotropes a été étudié in vivo par la technique de perfusion carotidienne in situ chez la souris et in vitro grâce à une lignée de cellules endothéliales cérébrales humaines immortalisées (hCMEC/D3). Nous avons démontré que la haute perméabilité cérébrale de la cocaïne fait intervenir à la fois une diffusion passive et surtout une diffusion médiée par un antiport proton. La vitesse d’entrée des substances d’abus dans le cerveau est associée à un plus fort risque d’addiction et fait de ce transporteur un nouvel acteur critique de la régulation du passage cérébral. En effet, d’autres substances comme la nicotine et certaines amphétamines comme le MDPV et l'ecstasy sont également des substrats de cet antiport. Ce transporteur apparaît comme une cible pharmacologique potentielle dans la prise en charge de toxicomanies. Malgré la diversité chimique et pharmacologique d’interactions des composés avec cet antiport, les concentrations nécessaires pour l’inhiber dépassent celles retrouvées dans le sang. Pour aider l’identification d’inhibiteurs sélectifs et efficaces nous avons développé un modèle pharmacophorique d’inhibiteurs du transporteur à partir de données générées in vitro et de l’approche FLAPpharm. Ce modèle semble prédictif de nouveaux composés pouvant constituer de meilleurs inhibiteurs de ce transporteur. L’étude des échanges in vivo au niveau du tissu nerveux nous a menés à étudier l’impact de transporteurs ABC et de l’antiport-proton au niveau cérébral et rétinien à l’aide de substances spécifiques ou de substrats mixtes comme le vérapamil. L’antiport proton est fonctionnel au niveau de la BHR et transporte notamment la clonidine, le DPH et le vérapamil. Cependant, dans le cas d’un substrat mixte P-gp et SLC (ex : vérapamil), ce transport d’influx n’est visible à la BHE que lorsque la P-gp est neutralisée. Au contraire, à la BHR l’influx lié à cet SLC est visible naturellement. L’impact de la P-gp à la BHR étant 6.3-fois plus faible ce processus est probablement moins masqué. Cette étude illustre la difficulté actuelle de prédire l’impact fonctionnel d’un transporteur pour des substrats multi-spécifiques et l’existence d’une priorisation du transport. Enfin, nous avons essayé d’identifier l’antiport proton au niveau moléculaire par une méthode de photo-activation à l’aide d’un composé adapté. Cette méthode s’est avérée efficace pour fixer une molécule sur le transporteur, permettant par la suite de l’isoler plus facilement. En conclusion, ce travail a permis de mettre en évidence l’importance de l’antiport proton dans la distribution cérébrale de psychotropes et d’ouvrir de nouvelles perspectives dans l’addiction et la compréhension du transport de substrats multi-spécifiques. / The central nervous system is a privilege organ protected by histological barriers between the blood and the nervous tissue. The blood-brain barrier (BBB) and the blood-retinal barrier (BRB) separate cerebral parenchyma and retina from the circulating blood and both express tight junctions and membrane transporters, allowing a precise regulation of the exchanges between the blood and nervous tissues. We studied a new cationic transporter functionally evidenced at the mouse BBB. This molecularly unknown transporter belong to the solute carrier super family (SLC) and is a proton antiporter. It could constitute a new actor in the cerebral permeability and may be a new brain access pathway. First, we worked on the functional identification studying new substrates and new localization. Psychotropic brain transport was studied in vivo by brain in situ perfusion on mouse and in vitro with human immortalized endothelial cells (hCMEC/D3). We showed that cocaine brain entry depends on passive diffusion but also mainly on a proton antiporter. Brain entry rate of drugs of abuse is associated with modulation of addiction liability, making this transporter a new component of brain entry of cocaine, and also nicotine and some amphetamines such as ecstasy and MDPV. This proton antiporter appears to be a new potential target in addiction. Various chemical entities interact with this transporter; however concentrations used to inhibit the transporter are much higher than the one possibly found in the blood. In order to help find or design new selective and potent inhibitors, we developed a pharmacophore model of the proton antiporter inhibitors using in vitro data and the FLAPpharm approach. The model predicts well new possible inhibitors of this transporter. We also studied the impact of the ABC transporters and the proton antiporter at the BBB and the BRB using specific or multi-specific substrates such as verapamil. The proton antiporter is functionally expressed at the BRB and transports clonidine, DPH and verapamil. However, for the multi-specific (P-gp and SLC) compound verapamil, influx transport by the proton antiporter is visible at the BBB only when P-gp efflux is neutralized. On the contrary, at the BRB, the proton antiporter influx is always visible. This is certainly due to the lower impact (by 6.3 fold) of P-gp at the BRB compared to the BBB. These results show the difficulty to predict the functional impact of a transporter for multi-specific compounds and a probable transport prioritization. Finally we worked on the molecular identification of the proton antiporter using a photolabeling method. This work evidenced the importance of the proton antiporter in the brain distribution of psychotropic and drugs of abuse and opened toward new perspectives in addiction and transport comprehension.

Como resultado do seu passado evolutivo, a família dos camarões Palaemonidae reúne representantes de ambientes osmóticos dos mais variados. Sejam de ambientes marinhos, estuarinos ou dulcícolas, estáveis ou variáveis, as espécies destes camarões mantêm a concentração osmo-iônica da hemolinfa independente da concentração do meio. Essas espécies hiper-regulam a osmolalidade e íons da hemolinfa em meio diluído e água doce e hipo-regulam em meio concentrado ou água do mar. Um importante local de transporte iônico envolvido na regulação osmo-iônica é o epitélio brânquial, pois nas membranas de seus ionócitos constituintes encontra-se um conjunto de transportadores que efetuam o movimento transepitelial de íons. Dentre estes transportadores, o simportador Na+, K+, 2Cl- (NKCC) é considerado ter um papel na secreção de sal, objetivo primário dessa investigação. Espécies representativas de habitat marinho do gênero Palaemon foram coletadas em regiões de estuário e de poça de maré, e de habitat dulcícola do gênero Macrobrachium foram coletadas em rios que desembocam no mar e também em riachos continentais sem influência do aporte salobro. Avaliou-se os limites letais de salinidade superior (LSS50) das espécies marinhas P. northropi e P. pandaliformis e dulcícolas diádromas M. acanthurus, M. olfersi, M. amazonicum que dependem de água salobra para completo desenvolvimento larval, e hololimnéticas M. potiuna e M. brasiliense com ciclo reprodutivo completo em água doce. Objetivou-se aqui (i) caracterizar os mecanismos de hiperregulação (condição controle de 18 S P. northropi, 17 S P. pandaliformis, água doce <0,5 S nas espécies de Macrobrachium) e hiporegulação [a curto (24 h) e longo prazo (120 h) em salinidade correspondente a 80% da LSS50] da osmolalidade e [Cl-] da hemolinfa, da expressão gênica e proteica e a localização por imunofluorescência do NKCC nos ionócitos branquiais; (ii) da existência de um padrão filogenético nesses parâmetros; e (iii) testar as hipóteses de um efeito da salinidade na evolução da expressão gênica e proteica desse simportador. As espécies de Palaemon apresentaram os maiores limites de tolerância ao aumento da salinidade, assim como exibiram uma maior capacidade hiporegulatória a longo prazo (120 h) comparada aos representantes de Macrobrachium. Dentre as espécies de Macrobrachium, os limites de tolerância foram maiores nas espécies diádromas do que nas hololimnéticas. Os parâmetros LSS50, osmolalidade e [Cl-] da hemolinfa demonstraram-se estruturados na filogenia, sendo as semelhanças compartilhadas justificadas pela estreita proximidade entre as espécies. As análises filogenéticas revelaram que a capacidade hiper-regulatória da [Cl-] da hemolinfa foi correlacionada com a expressão gênica do simportador NKCC nas brânquias, enquanto que a síntese proteica do NKCC parece estar associada à hiper-regulação da osmolalidade da hemolinfa. A avaliação da localização do NKCC por imunofluorescência demonstrou que o simportador está distribuído em ambas as células que compõem o epitélio das brânquias, as células pilares e células do septo intralamelar. A localização na porção inferior das franjas e no corpo da célula pilar e por toda célula do septo não diferiu entre as espécies, e também não difereiu entre as condições controle e a curto e longo prazo em salinidade elevada. Esses resultados em conjunto sugerem a importância do NKCC também na captação de sal pelas brânquias. Houve um aumento da síntese proteica do NKCC nas brânquias dos representantes de Macrobrachium, exceto M. potiuna, quando em salinidade elevada. Observou-se que este aumento é explicado pela proximidade filogenética entre as espécies. Não houve mudança na transcrição de RNAm para o NKCC apesar do aumento na síntese proteica, o que sugere uma possível regulação pós-transcricional. A reconstrução da história evolutiva da osmorregulação, incorporando o conceito de filofisiologia, revelou a existência de mecanismos em nível molecular, celular e sistêmico que evoluíram acompanhando os eventos cladogenéticos dos Palaemonidae durante a irradiação e ocupação de diferentes nichos osmóticos. / Owing to their evolutionary history, the shrimp family Palaemonidae includes species from widely distinct osmotic environments. Whether from marine, estuarine, or fresh waters, inhabiting stable or variable osmotic niches, these shrimps maintain the osmotic-ionic concentration of their hemolymph independently of the concentration of the external medium. These species hyper-regulate hemolymph osmolality and ions in dilute medium and fresh water and hypo-regulate this fluid in concentrated medium or seawater. The gill epithelium constitutes an important interface of ion transport, and its constituent ionocytes express an ensemble of ion transporters that enable active transepithelial ion movements. The Na+, K+, 2Cl- cotransporter (NKCC) is thought to play a significant role in compensatory salt secretion. Species representative of the marine habitat (Palaemon) were collected from estuaries and tidal pools; diadromous species from the fresh water habitat (Macrobrachium) were collected near the mouths of rivers that flow into the sea, while hololimnetic species were collected in continental streams lacking the influence of brackish waters. The critical upper salinity limits (LSS50) of the marine species P. northropi and P. pandaliformis and the diadromous freshwater species M. acanthurus, M. olfersi, M. amazonicum that depend on brackish water for complete larval development, and the hololimnetic M. potiuna and M. brasiliense that complete their reproductive cycle entirely in fresh water were established. Our objectives were to characterize the mechanisms of hyper-regulation (control condition 18 S P. northropi, 17 S P. pandaliformis, fresh water <0.5 S for Macrobrachium) and hypo-regulation [short-term (24 h) and long-term 120 h) at salinities corresponding to 80% of LSS50] of hemolymph osmolality and [Cl-], gene and protein expression, and NKCC localization for immunofluorescence in the gill ionocytes; (ii) the existence of a phylogenetic pattern in these parameters; and (iii) to test hypotheses for a salinity effect on the evolution of the gene and protein expression of this symporter. The species of Palaemon had the highest tolerance limits to increased salinity, and also exhibited a greater hypo-regulatory capacity for long-term acclimation compared to the species of Macrobrachium. Among the Macrobrachium species, the LSS50 were higher in the diadromous species than in the hololimnetic species. The parameters LSS50 and osmolality and [Cl-] of the hemolymph were phylogenetically structured, similarities being shared by closely related species. The hyper-regulatory capacity of hemolymph [Cl-] correlated with NKCC gene expression in the gills, while NKCC protein synthesis appears to be associated with hyper-regulation of hemolymph osmolality. Immunofluorescence analysis showed that the NKCC was located in both cell types that constitute the gill epithelium, the pillar cells and the septal cells. The location of the NKCC in the lower flanges and perikarya of the pillar cells and throughout the septal cells, did not differ among species, and also did not differ among control conditions or short and long-term exposure at high salinity. These results together also suggest the importance of the NKCC in salt uptake by the gills. When in high salinity there was an increase in NKCC protein synthesis in the gills of the Macrobrachium species, except for M. potiuna. This increase can be explained by the phylogenetic proximity among those species, which excludes adaptive inferences. There was no change in NKCC mRNA transcription, which suggests possible post-transcriptional regulation. The reconstruction of the evolutionary history of osmoregulation, incorporating the concept of phylophysiology, revealed the existence of mechanisms at the molecular, cellular and systemic levels that have evolved accompanying the cladogenetic events of the Palaemonidae during their radiation and occupation of different osmotic niches.

ATP-Binding-Cassette (ABC) transporters are primary active pumps that typically couple the binding and hydrolysis of ATP to the translocation of compounds across cellular membranes. Some, like ABCB1, ABCC1 and ABCC3, are polyspecific and can efflux clinically important drugs which may contribute to their therapeutic failure. In this study I have investigated (1) the mechanism of ABC transporter function, (2) studied the potential for regulation by ubiquitin ligases (both using ABCB1 as a model), and (3) tested the involvement of ABCC1 and ABCC3 in autocrine signalling in cancer. (1) In 1966, Jardetzky et. al [1] proposed that membrane pumps function by exposing their ligand-binding pocket alternately on different sides of the membrane. For ABC transporters, this coupling of the aspect and affinity of the ligand-binding cavities of the two transmembrane domains (TMDs) to the ATP catalytic cycle of the two nucleotide-binding domains (NBDs) is fundamental to the transport mechanism but is poorly understood at the molecular level. Structure data suggest signals are transduced through intracellular loops of the TMDs which slot into grooves on the top surface of the NBDs. At the base of these grooves is the Q-loop. By analysing the function of Q-loop mutants in combination with ligand binding cavity mutants I have discovered that the Q-loops are crucial to the transport cycle and that they are required to couple ligand binding to conformational changes at the NBDs necessary to drive the transporter into an inward closed state. 4 (2) ABCB1 is known to be a key component of chemical barrier separating the circulation from the cerebrospinal fluid. It has also been reported to transport β-amyloid across the lumenal membrane and into the circulation. Loss of ABCB1 from the barrier with age has therefore been suggested to play a role in Alzheimer’s Disease. The ubiquitin ligase Nedd4-1 has been implicated in the post-translational regulation of ABCB1 abundance in cells. Here, I report that ABCB1 can be ubiquitinated by Nedd4-1 in vitro and identify the residues modified (by mass spectrometry). (3) Lysophosphatidylinositol (LPI) is an autocrine metabolite produced by cancer cells that binds to the G-protein coupled transmembrane receptor GPR55 on the surface of cells. Stimulation of GPR55 activates a signalling cascade that induces proliferation and metastases of the cancer cells. How LPI is released from the cells was not known. In this study I show that ABCC1 and ABCC3, which are known to be expressed in ovarian and pancreatic cancers, can transport LPI into inside-out vesicles suggesting a new role for these “drug resistance” transporters in cancer biology.

O enxofre é um dos elementos essenciais para as plantas e as exigências nutricionais nesse nutriente variam com a espécie e a taxa de crescimento das plantas. Com o objetivo geral de avaliar o efeito da nutrição em enxofre no crescimento e no metabolismo do capimtanzânia (Panicum maximum cv. Tanzânia) e do estilosante (Stylosanthes guianensis cv. Mineirão) desenvolveu-se a presente pesquisa com os objetivos específicos de avaliar os efeitos do fornecimento de enxofre em: i) modificações morfológicas, produtivas e nutricionais ocorridas na parte aérea e nas raízes; ii) metabolismo do nitrogênio e as consequentes alterações na composição e concentrações de aminoácidos; iii) concentrações de enxofre total, enxofre-sulfato e glutationa e na atividade das enzimas glutationa redutase e glutationa sulfo-transferase nas folhas recém-expandidas e raízes; iv) crescimento, metabolismo da glutationa e atividade das enzimas envolvidas no ciclo ascorbato-glutationa e v) absorção de sulfato e a expressão de genes de transportadores de sulfato. Os experimentos foram conduzidos em casa de vegetação e camara de crescimento, empregando-se soluções nutritivas. As doses de enxofre aplicadas foram ajustadas de modo a permitir nutrição baixa, intermediária e alta em enxofre para cada espécie. O enxofre afetou diretamente na emissão de folhas e de perfilhos, área foliar, comprimento e superfície radicular do capim-tanzânia e do estilosante Mineirão, aumentando a produção de massa seca da parte aérea e das raízes. A baixa disponibilidade de enxofre ocasionou o desequilíbrio nutricional com o nitrogênio nas plantas, evidenciado por alta relação nitrogênio:enxofre e altas concentrações de nitrato e aminoácidos livres no tecido vegetal. Sob limitação de enxofre, o capim apresentou predomínio de asparagina na composição aminoacídica, enquanto no estilosante ocorreu a predominância de arginina. A aplicação de enxofre aumentou as concentrações de enxofre total, enxofre-sulfato e glutationa nas folhas diagnósticas e raízes para ambas as espécies forrageiras. As plantas crescidas sob limitação de enxofre apresentaram alta atividade da enzima glutationa redutase visando regenerar a glutationa reduzida, que atua protegendo as células contra danos oxidativos decorrentes do estresse da deficiência nutricional. O fornecimento de enxofre aumentou a atividade da glutationa sulfo-transferase incrementando a capacidade do vegetal de suportar estresses ambientais. A baixa disponibilidade de enxofre induziu o aumento da atividade de enzimas antioxidantes que atuam na regeneração da glutationa e do ascorbato na forma reduzida. As plantas crescidas em baixa disponibilidade de enxofre apresentaram aumento da concentração de glutationa e maior alocação desse composto nas raízes. A distribuição de glutationa das folhas para as raízes em condição de limitação de enxofre regula a absorção de sulfato no capim e no estilosante de modo diferenciado. Para o capim com alta concentração de glutationa nas raízes decresce o influxo total de 34S, enquanto para o estilosante não ocasiona a redução da absorção de sulfato. / Sulfur is an essential element required by plants and the nutritional requirements in this nutrient vary according to species and plant growth rate. This research had the main objective of evaluating the effect of sulfur nutrition on growth and metabolism of Guinea grass (Panicum maximum cv. Tanzânia) and stylo (Stylosanthes guianensis cv. Mineirão) and was developed with the specific objectives to determine the effects on i) morphological, productive and nutritional changes in plant shoots and roots, ii) nitrogen metabolism and the changes in the composition and concentrations of amino acids, iii) concentrations of total sulfur, sulfur-sulfate and glutathione and the activity of the enzymes glutathione reductase and glutathione sulfo-transferase in recently expanded leaves and roots, iv) growth, glutathione metabolism and activity of enzymes involved in ascorbate-glutathione cycle and v) sulfate uptake and expression of sulfur transporters genes. The experiments were carried out in greenhouse and growth chamber, by using nutrient solutions. Sulfur supply were adjusted to low, intermediate and high S nutrition for each species. Sulfur supply influences the emission of leaves, tillering, leaf area, root length and surface of Guinea grass and stylo increasing production of dry mass of aboveground and roots. Sulfur limitation alters the distribution of photosynthates between aboveground and roots of Guinea grass and stylo providing reduction in dry matter production of roots. The plants of Guinea grass increase root surface as a mechanism for adaptation to limited S in the culture medium. The relative chlorophyll index (RCI) in the recently expanded leaves relates to the production of dry mass of aboveground and can be used to assess S nutritional status in Guinea grass and stylo. The application of S proves necessary to increase production of dry mass in Guinea grass and stylo. Low S availability caused nutritional imbalance with N in Guinea grass and stylo plants, as shown by a high N:S ratio and high concentrations of N-nitrate and free amino acids in plant tissues. Among amino acids, asparagine predominated in S-limited guineagrass and arginine in Slimited stylo. Increased S supply regulates N:S ratio at values close to 20:1, which provides N and S concentrations that are more suitable for protein synthesis and forage production in plants of both species. Adding S increased concentrations of total S, S-sulfate, and glutathione in diagnostic leaves and roots of both species collected at the two harvests. Plants grown under S limitation showed high levels of GR activity, related to the regeneration of GSH, which acts to protect cells against oxidative damage caused by the stress of nutritional deficiency. S supply increased GST activity, and consequently plants\' capacity to withstand environmental stresses. Low S availability increased activity of the antioxidant enzymes that act in the regeneration of GSH and AsA. Plants grown with low S availability showed higher concentration of glutathione and greater allocation of glutathione to roots. For Guinea grass, high glutathione concentrations in roots decrease the 34S uptake. For stylo not cause reduction of 34S uptake.

Centrado no carcinoma colorretal, o presente trabalho visou: 1) Estudar a distribuição das principais variáveis anatomopatológicas, pesquisando sua associação com metástase linfonodal ou hepática. 2) Com base nas eventuais associações encontradas, selecionar um conjunto de variáveis que, estudadas no tumor primário, possam predizer a presença de metástase nodal ou hepática. 3) Analisar os perfis de imunoexpressão de alguns marcadores potencialmente relacionados à citoarquitetura (queratina 7 e 20) e ao crescimento tumoral (proliferação através do Ag Ki-67 e apoptose através da queratina 18 clivada) em amostras de mucosa normal, adenocarcinoma primário, metástase linfonodal e metástase hepática, explorando suas eventuais relações com as variáveis histopatológicas e o estadio da lesão. 4) Pesquisar possíveis associações entre a expressão dos transportadores de monocarboxilato 1, 2 e 4, moléculas reguladoras do pH intracelular, e os marcadores acima relacionados e as variáveis anatomopatológicas. A casuística foi constituída por 139 adenocarcinomas colorretais, sendo 96 sem metástase hepática e 39 com metástase hepática. Os casos foram revistos e 13 variáveis anatomopatológicas foram selecionadas para fazer parte do estudo. Foram confecionados manualmente blocos de microarranjos teciduais (TMA) de mucosa normal, tumor primário, metástase linfonodal e metástase hepática, cujos cortes foram submetidos a estudo imuno-histoquímico utilizando anticorpos anti queratina 7 (K7), queratina 20 (K20), Ki-67 e queratina 18 clivada. Em 126 blocos de parafina de tumores, e 86 amostras de mucosa normal correspondentes foram submetidos a estudo imuno-histoquímico utilizando anticopos anti transportadores de monocarboxilato 1, 2 e 4 (MCT1, MCT2 e MCT 4). A presença de metástase linfonodal asociou-se estatisticamente com a presença de infiltração tumoral além da camada muscular própria (T3 ou T4) (p<0,001), presença de desmoplasia tumoral moderada / intensa (p=0,043), presença de infiltração de vasos linfáticos (p<0,001), presença de infiltração venosa (p<0,001) e presença de infiltração tumoral perineural (p<0,001). A presença de metástase hepática teve associação estatisticamente significativa com a presença de infiltração tumoral além da camada muscular própria (p = 0,004) e com a presença de bordas tumorais infiltrativas ( p=0,05). As amostras de mucosa colorretal normal apresentaram baixa freqüência de positividade para a queratina 7, o mesmo ocorrendo com os adenocarcinomas primários e as metástases linfonodais. Detectamos, entretanto, diferença estatística significante entre a maior imunoexpressão da K7 nas metástases hepáticas quando comparadas aos adenocarcinomas primários (p<0,001) e às metástases linfonodais (p=0,015). Conforme esperado a queratina 20 mostrou-se presente na quase totalidade das amostras de mucosa colorretal normal e em mais de 90% das amostras dos vários tipos de lesão aqui estudadas. A taxa de proliferação nos adenocarcinomas primários foi significantemente superior à da observada na mucosa normal (p<0,001). Não houve diferenças estatísticas entre as taxas proliferativas das amostras neoplásicas. O índice de células em apoptose foi estatisticamente significante mais elevado nos adenocarcinomas primários que na mucosa normal (p<0,001), assim como foi mais elevado nas metástases hepáticas em relação aos adenocarcinomas primários (p=0,022). Tumores maiores que 5 cm apresentaram índices apoptóticos mais elevados que aqueles menores que 5 cm (p=0,005). As expressões citoplasmática e membranosa dos MCT1 e 4 foram mais frequentes nos adenocarcinomas que nas mucosas normais (p<0,001). A expressão membranosa do MCT1 associou-se à presença de infiltração linfática (p=0,004) , infiltração sangüínea (p=0,018) e à presença de índices apoptóticos mais elevados. Em conclusão, dentre as variáveis histológicas, infiltração linfática tumoral e infiltração de vasos sangüíneos foram fatores de risco independentes para metástase linfonodal e infiltração tumoral além da muscular própria e a presença de bordas tumorais infiltrativas foram fatores de risco independentes para metástase hepática nas análises multivariadas. A queratina 7 foi mais frequentemente expressa nas metástases hepáticas que nas metástases linfonodais e adenocarcinomas primários, indicando que a aquisição da expressão da queratina 7 pode ser uma alteração tardia do citoesqueleto associada a maior agressividade do tumor. A proliferação celular marcada pelo Ag Ki-67 assim como a apoptose, marcada pela queratina 18 clivada mostraram significativo incremento do normal para o adenocarcinoma primário e suas respectivas metástases. Os MCTs foram mais expressos nos adenocarcinomas que nas mucosas normais, sugerindo possível interferência de seu papel no controle do pH intracelular nestas neoplasias / The aims of this study in colorectal carcinoma were: 1) Verify the distribution of the most important anatomopathological variables, and identifying their relationship with lymph node or liver metastasis. 2) Considering the associations obtained in the first aim, a group of variables was selected to verify the prediction of lymph node or liver metastasis. 3) Analyze the immunoprofile of both markers associated with cytoarchitecture (keratins 7 and 20) and with tumor growth (proliferation and apoptosis using Ki-67 and cleaved keratin 18, respectively) in samples of nontumoral mucosa, primary adenocarcinoma, lymph node metastasis and liver metastasis, exploring the eventual relation with anatomopathological variables and tumor stage. 4) Look for possible associations between molecules related to intracellular pH control, as monocarboxylates transporters 1, 2 and 4, and the markers above mentioned and anatomopathological variables. One hundred and thirty nine colorectal carcinomas is the universe of the casuistic, 96 of them without liver metastasis and 39 metastatic to the liver was studied. Thirteen anatomopathological variables were selected and semi-quantified. We mannualy builted tissue microarrays (TMAs) of non tumoral mucosa, primary adenocarcinoma, lymph node metastasis and liver metastasis. The histological sections from the TMAs were submmitted to immunohistochemical study using antibodies against keratin 7 (K7), keratin 20 (K20), Ag Ki-67 and cleaved keratin 18. In 126 tumor paraffin blocks, 86 of which also had non tumoral mucosa were submitted to immunohistochemical stain using antibodies against monocarboxylate transportes 1, 2 and 4 (MCT1, MCT2 e MCT 4). Lymph node metastasis was associated with tumor infiltration across muscularis propria(p<0,001), moderate / intense desmoplasia(p=0,043), lymph vessel infiltration(p<0,001), venous infiltration (p<0,001) and perineural infiltration (p<0,001). Liver metastasis was statistically associated with tumor infiltration across muscularis propria and infiltrative tumor borders ( p=0,05). Few colorectal mucosa samples, as well as primary tumor and lymph node metastasis showed immunoexpression of K7, although we found statistically significant higher immunoexpression of K7 in liver metastasis as compared with primary carcinomas (p<0,001) and with lymph node metastasis (p=0,015). As expected, K20 was expressed in more than 90% of the samples examined. Higher Ki-67 rates were found in adenocarcinoma compared with normal mucosa (p<0,001). We did not find statistical differences of proliferation rates between neoplastic samples. Apoptotic index were higher in primary adenocarcinomas than in normal mucosa ( p<0,001), and was also higher in liver metastasis than in primary adenocarcinoma (p=0,022). We also found higher apoptotic index in tumors that measured more than 5 cm (p=0,005). Membranous and cytoplasmic expression of MCTs 1 and 4 were found more frequently expressed in adenocarcinoma than in non neoplastic mucosa (p<0,001). Membranous MCT1 expression was associated with lymph vessel infiltration (p=0,004), venous infiltration (p=0,018) and with higher apoptotic index. Lymphatic vessel infiltration and venous vessel infiltration were found as independent risk factors for lymph node metastasis. Tumor infiltration across muscularis propria and infiltrative tumor borders were also independent risk factor for liver metastasis by multivariate analysis. Keratin 7 were more frequently expressed in liver metastasis samples than in lymph node metastasis and primary adenocarcinomas, indicating that the acquisition of K7 expression could be a late cytoskeleton alteration associated with higher tumor aggressiveness. Proliferation rates as well as higher frequency of apoptosis, showed increased expression from normal mucosa to primary adenocarcinoma and its respective metastasis. Finally, monocarboxylate transporters were higher expressed in adenocarcinoma samples than in normal mucosa samples indicating a probable role in the intracellular pH in colorectal neoplasia

Produtos de glicação avançada (AGE) alteram o metabolismo de lípides e, em especial, o efluxo de colesterol de macrófagos, por meio da redução dos receptores ABCA-1 e ABCG-1. Isto prejudica o transporte reverso de colesterol, sistema que favorece o fluxo de colesterol de macrófagos arteriais ao fígado, permitindo sua excreção na bile e eliminação fecal. Óxidos de colesterol modulam favoravelmente a homeostase lipídica em macrófagos e favorecem o transporte reverso de colesterol, embora o acúmulo de 7-cetocolesterol, 7-hidroxicolesterol e 7-hidroxicolesterol associe-se à aterogênese e morte celular. Neste estudo, avaliou-se o efeito do tratamento com glicolaldeído (GAD; oxoaldeído que induz rápida geração intracelular de AGE), em macrófagos sobrecarregados com LDL oxidada e incubados com HDL ou HDL e indutor de LXR (T0901317) sobre: 1) a distribuição seletiva de óxidos de colesterol e o conteúdo total de esteróis intracelulares e 2) o conteúdo de ABCA-1 e ABCG-1. Colesterol total e os diversos subtipos de óxidos de colesterol foram determinados por cromatografia a gás acoplada à espectrômetro de massa. O conteúdo dos receptores de HDL (ABCA-1 e ABCG-1) foi avaliado por imunoblot. Em macrófagos controles (C), a adição de HDL ou HDL + T0901317 promoveu redução no conteúdo de esteróis totais (colesterol + óxidos de colesterol), colesterol e 7-cetocolesterol. No entanto, isto não foi observado em macrófagos GAD. Nas diversas condições experimentais, não houve diferença no conteúdo intracelular dos outros subtipos de óxidos de colesterol, em células C e GAD. Macrófagos GAD apresentaram menor conteúdo de ABCA-1 (45%), quando comparados aos macrófagos C, mesmo após adição de HDL ou HDL + T0901317. O conteúdo de ABCG-1 foi 36,6% menor em macrófagos GAD, na presença de HDL, em comparação às células C. Em conclusão, em macrófagos sobrecarregados com LDL oxidada, o tratamento com glicolaldeído diminui a exportação celular de colesterol e 7-cetocolesterol, mediada pela HDL. Isto é decorrente do menor conteúdo dos receptores ABCA-1 e ABCG-1 em macrófagos tratados com glicolaldeído, e pode contribuir para o desenvolvimento de aterosclerose no diabete melito / Advanced glycation end products (AGE) alter lipid metabolism and reduce the macrophage expression of ABCA-1 and ABCG-1 which impairs the reverse cholesterol transport, a system that drives cholesterol from arterial wall macrophages to the liver, allowing its excretion into the bile and feces. Oxysterols favors lipid homeostasis in macrophages and drive the reverse cholesterol transport, although the accumulation of 7-ketocholesterol, 7- hydroxycholesterol and 7- hydroxycholesterol is related to atherogenesis and cell death. We evaluated the effect of glycolaldehyde treatment (GAD; oxoaldehyde that induces a fast formation of intracellular AGE) in macrophages overloaded with oxidized LDL and incubated with HDL alone or HDL plus LXR agonist (T0901317) in: 1) the intracellular content of oxysterols and total sterols and 2) the contents of ABCA-1 and ABCG-1. Total cholesterol and oxysterol subspecies were determined by gas chromatography/mass spectrometry and HDL receptors content by immunoblot. In control macrophages (C), incubation with HDL or HDL + T0901317 reduced the intracellular content of total sterols (total cholesterol + oxysterols), cholesterol and 7-ketocholesterol, which was not observed in GAD macrophages. In all experimental conditions no changes were found in the intracellular content of other oxysterol subspecies comparing C and GAD macrophages. GAD macrophages presented a 45% reduction in ABCA-1 protein level as compared to C cells, even after the addition of HDL or HDL + T0901317. The content of ABCG-1 was 36.6% reduced in GAD macrophages in the presence of HDL as compared to C macrophages. In conclusion, in macrophages overloaded with oxidized LDL, glycolaldehyde treatment reduces the HDL-mediated cholesterol and 7-ketocholesterol efflux which is ascribed to the reduction in ABCA-1 and ABCG-1 protein level. This may contribute to atherosclerosis in diabetes mellitus

The organic cation transporters (OCTs) play a critical role in the absorption, distribution and elimination of many drugs, hormones, herbal medicines, and environmental toxins. Given the broad substrate specificity of OCTs, they fall victim to the high susceptibility for contributing to harmful drug-drug interactions. Further defining how human (h)OCTs mechanistically bind to its broad array of substrates will provide significant insight to the understanding and prediction of drug-drug interactions in polypharmacy patients and the advancement of future rational drug design for therapeutics targeting OCTs. The goal of the current study was to elucidate the critical amino acid residues for transporter-substrate binding interactions on human (h)OCT1 and 2 utilizing in silico molecular modeling techniques (homology modeling and automated docking), as well as in vitro mutagenesis and kinetic transport experiments. Three-dimensional homology models were generated for hOCT1 and 2 using Piriformospora indica phosphate transporter (PiPT) serving as template. A putative binding pocket was identified and used to dock the prototypical substrate MPP+. Docking studies revealed five residues for each transporter (hOCT1 and hOCT2) that may be critical for substrate-transporter interactions. The in silico data was used to guide subsequent in vitro site-directed mutagenesis and kinetic analysis. Four hOCT1 mutants (Gln241Lys, Thr245Lys, Tyr361Ala, and Glu447Lys) and three hOCT2 mutants (Gln242Lys, Tyr362Phe, and Tyr362Ala) showed complete loss of MPP+ transporter activity. Decreased affinity for MPP+ was observed for Phe244Ser and Thr245Ser in hOCT1, and Tyr245Ala in hOCT2. All amino acid residues highlighted in the in vitro experiments may be potentially critical for substrate-transporter interactions particularly Tyr361, Phe244 and Thr245 in hOCT1; and Tyr362 and Tyr245 in hOCT2. Docking of known structurally divergent hOCT1 and hOCT2 substrates revealed similar binding interactions as that identified for MPP+, albeit with some unique residues, suggesting the presence of a large central cavity within both transporters. Through the combination of in silico and in vitro experiments, a putative binding pocket was defined and several residues important for substrate-transporter interaction were identified and verified for hOCT1 and hOCT2. Further defining how OCTs biochemically interact with their broad array of substrates will provide significant insight to the understanding and prediction of drug-drug interactions in polypharmacy patients and the advancement of future rational drug design for therapeutics targeting OCT1 and OCT2.

Ligands of the human monoamine transporters encompass a wide range of both illicit and therapeutic drugs that act upon neural circuitry related to reward, motivation, and the processing of salient stimuli. The present study utilizes two methods for analyzing transporter substrates and inhibitors in order to characterize activity and assess potency. The first measures transient changes in intracellular calcium as a surrogate for transporter activity by harnessing the electrical coupling of monoamine transporters and L-type calcium channels. This is used to analyze novel chimera of the strong hDAT inhibitors methylphenidate and 𝛼-PPP in order to assess the contribution of specific moieties to potency. The observed reduction in potency suggests that methylphenidate may bind to the transporter in a manner distinct from 𝛼-PPP, as chimera would otherwise be expected to show similar activity to parent compounds. These results highlight the importance of 𝛼-carbon substituents and the relatively small contribution of beta-carbon groups to inhibitor potency at hDAT, while the lack of activity at hSERT suggests potency is not strongly influenced by beta-carbon or N-alkyl substituents. In order to further characterize drug-transporter interaction, a method was developed to analyze the kinetics of binding and unbinding using both known and novel hNET ligands, including a series of N-alkyl derivatives of 4-methylamphetamine. The study emphasizes the importance of both association and dissociation kinetics to affinity and sets up a methodological framework with two ways for determining Kd, with notable advantages over current models. The results indicate that lengthening the N-alkyl chain of 4-methylamphetamine leads to a decrease in potency and a shift in activity from substrate to blocker, with the results of N-propyl 4-methylamphetamine in particular indicating the potential existence of multiple low-affinity binding sites, each with distinct on and off kinetics. The implications of these results help elucidate the mechanism of action of transporter ligands and set up a framework for future studies that can more specifically classify the interaction between transporters and inhibitors or releasing agents.

<p>The appearance of adverse drug reactions is a common reason for hospitalization in Western countries. Research on underlying biological mechanisms for interindividual variability in drug response aims to better identify patients with exceptional genetic traits, disease conditions or risk of drug-drug interactions and thereby help to prevent adverse drug reactions. </p><p>Active transport mechanisms are involved in the absorption and disposition of several therapeutic agents. The main objective of this thesis was to investigate factors potentially affecting transport proteins and thus contributing to variability in drug absorption and disposition. Studies of physiological, genetic, environmental, and pathological factors were included. The main focus was the two ATP-binding cassette (ABC) transporters: P-glycoprotein 170 (Pgp) and Breast Cancer Resistance Protein (BCRP). </p><p>Quantification of transport protein mRNAs along the human intestine indicated that eight of the nine investigated drug transporters were expressed in a region-dependent manner. Effects of drug-drug interactions may therefore vary depending on the site of absorption. The genetic aspect was illustrated by identification of sequence variation in the gene encoding BCRP, the most highly expressed ABC transporter along the human intestine. Drug-drug interactions are important environmental causes of interindividual variability. An evaluation of the effects of Pgp-mediated drug-drug interactions showed that patients receiving Pgp inhibitors had elevated serum concentrations of the Pgp substrate digoxin and that digoxin concentrations were positively correlated with the number of co-administered Pgp inhibitors. The final topic in this thesis was that of drug-disease interactions. BCRP and Pgp were down-regulated during active inflammation in patients with ulcerative colitis. This may contribute to altered concentrations of drug in the intestinal mucosa during periods of inflammation and possibly to changes in drug absorption.</p><p>To summarize, results of this thesis emphasize the complex background to the interindividual variability of drug transport proteins, where physiological, genetic, environmental and pathological factors all can contribute.</p>

The appearance of adverse drug reactions is a common reason for hospitalization in Western countries. Research on underlying biological mechanisms for interindividual variability in drug response aims to better identify patients with exceptional genetic traits, disease conditions or risk of drug-drug interactions and thereby help to prevent adverse drug reactions. Active transport mechanisms are involved in the absorption and disposition of several therapeutic agents. The main objective of this thesis was to investigate factors potentially affecting transport proteins and thus contributing to variability in drug absorption and disposition. Studies of physiological, genetic, environmental, and pathological factors were included. The main focus was the two ATP-binding cassette (ABC) transporters: P-glycoprotein 170 (Pgp) and Breast Cancer Resistance Protein (BCRP). Quantification of transport protein mRNAs along the human intestine indicated that eight of the nine investigated drug transporters were expressed in a region-dependent manner. Effects of drug-drug interactions may therefore vary depending on the site of absorption. The genetic aspect was illustrated by identification of sequence variation in the gene encoding BCRP, the most highly expressed ABC transporter along the human intestine. Drug-drug interactions are important environmental causes of interindividual variability. An evaluation of the effects of Pgp-mediated drug-drug interactions showed that patients receiving Pgp inhibitors had elevated serum concentrations of the Pgp substrate digoxin and that digoxin concentrations were positively correlated with the number of co-administered Pgp inhibitors. The final topic in this thesis was that of drug-disease interactions. BCRP and Pgp were down-regulated during active inflammation in patients with ulcerative colitis. This may contribute to altered concentrations of drug in the intestinal mucosa during periods of inflammation and possibly to changes in drug absorption. To summarize, results of this thesis emphasize the complex background to the interindividual variability of drug transport proteins, where physiological, genetic, environmental and pathological factors all can contribute.